|
000
| 01833cam 2200301za 4500 |
|---|
| 001 | 9.864389 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107161528 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 181107s2018 onc #o f000 0 eng d |
|---|
| 020 | |a9780660284279 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-250/2018E-PDF |
|---|
| 245 | 00|aNotifying Health Canada of foreign actions |h[electronic resource] : |bguidance document for industry. |
|---|
| 260 | |aOttawa : |bHealth Canada, |c2018. |
|---|
| 300 | |aiii, 7 p. |
|---|
| 500 | |aIssued also in French under title: Aviser Santé Canada des mesures prises dans les pays étrangers : document d’orientation à l’intention de l’industrie. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 520 | |a"The purpose of this guidance document is to provide manufacturers, importers and other holders of instruments of market authorization (Drug Identification Numbers (DIN) and Notices of Compliance (NOC)) under the Food and Drug Regulations, with information that may be useful in achieving compliance with the regulatory requirements of notification to Health Canada of foreign regulatory actions as outlined in sections C.01.050 (2)(a), (b) and (c) and C.01.050 (3) of the Food and Drug Regulations"--Introduction, p. 1. |
|---|
| 692 | 07|2gccst|aRegulations |
|---|
| 692 | 07|2gccst|aHealth care products |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tAviser Santé Canada des mesures prises dans les pays étrangers |w(CaOODSP)9.864391 |
|---|
| 856 | 40|qPDF|s364 KB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-250-2018-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/foreign-actions-profile/guidance-document.html |
|---|